Home

United States

Search form

  • Home
  • Products
    • Dexcom SEVEN PLUS
    • DM3 Software
    • Mobile Apps
  • About CGM
    • Glucose Control
    • Insight
    • For Injection Therapy
  • Customer Care
    • Contact Us
    • Request Information
    • Getting Started
    • FAQ & How To
  • Dexcom Circle
    • Heroes
    • News
  • Healthcare Professionals
    • Hypoglycemia
    • Compliance
    • Patient Selection
    • CGM Resource Center
    • Clinical Research
  • About Dexcom
    • Breaking News
    • Management and Board of Directors
    • Investor Relations
      • Stock Info
      • SEC Filings
      • Printed Materials
      • Email Alerts
      • Events & Webcasts
      • Corporate Governance
    • Press Releases
    • Careers
    • Location

Close
  • Česká Republika
  • Deutschland
  • España
  • France
  • Italia
  • עברית
  • Nederlands
  • Österreich
  • Slovenská Republika
  • Suomi
  • Sverige
  • United Kingdom
  • United States

  • Breaking News
  • Management and Board of Directors
  • Investor Relations
  • Press Releases
  • Careers
  • Location

Investor Relations

Dexcom, Inc. (NASDAQ:DXCM)

Dexcom is leading the way to exciting new technologies.

  • Stock Info
  • SEC Filings
  • Printed Materials
  • Email Alerts
  • Events & Webcasts
  • Corporate Governance
Contact Investor Relations: InvestorRelations@Dexcom.com
Site Map  |  International  |  Terms of Use  |  Notice of Privacy Practices  |  Privacy Policy  |  Safety Information

©2011 Dexcom, Inc. All rights reserved. This product is covered by U.S. patent.
Dexcom®, SEVEN®, STS®, BETWEEN THE LINES™, STAY BETWEEN THE LINES®, TAKE CONTROL — LIVE UNINTERRUPTED®,
LIVE UNINTERRUPTED™, DEXCOM DM®, DEXCOM DATA MANAGER®, OpenChoice™, and SenSync™ are trademarks and registered trademarks of Dexcom, Inc. All other trademarks and registered trademarks are the property of their respective owners.

Customer Care: 1-888-738-3646
LBL 010885 Rev02